Immuneering reported net income of -$17.44M for the quarter ended Jun 2026. This income statement covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 18.29M | 13.61M | 26.38M | 26.39M | 26.40M | 26.42M | 26.50M | 29.26M | 29.27M | 29.27M | 29.65M | 29.65M | 31.05M | 31.05M | 35.99M | 35.99M | 39.67M | 44.01M | 64.69M | 64.70M | |||||
| Revenue & cost | |||||||||||||||||||||||||
| Revenue | 0.48M | 0.19M | 0.18M | 0.09M | 0.04M | 455.00 | |||||||||||||||||||
| Gross Profit | 0.26M | -0.02M | 0.09M | 0.05M | 0.02M | 455.00 | |||||||||||||||||||
| Operating items | |||||||||||||||||||||||||
| Amortization - Intangibles | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | |||||||
| Research & DevelopmentR&D | 6.21M | 7.95M | 9.06M | 7.98M | 9.36M | 9.87M | 10.21M | 9.45M | 10.05M | 11.91M | 11.20M | 10.65M | 11.25M | 14.86M | 11.47M | 10.45M | 10.87M | 9.25M | 10.65M | 14.00M | |||||
| Selling, General & AdministrativeSG&A | 2.60M | 3.15M | 3.95M | 3.70M | 3.84M | 4.11M | 4.46M | 4.04M | 3.87M | 4.38M | 4.12M | 4.25M | 4.01M | 3.69M | 4.01M | 4.30M | 4.51M | 4.49M | 4.68M | 5.00M | |||||
| Other Operating ExpensesOther Opex | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | |||||||
| Operating ExpensesOpex | 8.81M | 11.10M | 13.02M | 11.69M | 13.21M | 13.99M | 14.68M | 13.50M | 13.93M | 16.30M | 15.33M | 14.91M | 15.27M | 18.56M | 15.48M | 14.76M | 15.38M | 13.75M | 15.34M | 19.00M | |||||
| Operating IncomeOp. Inc | -8.54M | -11.12M | -12.93M | -11.65M | -13.19M | -13.99M | -14.68M | -13.50M | -13.93M | -16.30M | -15.33M | -14.91M | -15.27M | -18.56M | -15.48M | -14.76M | -15.38M | -13.75M | -15.34M | -19.00M | |||||
| EBIT | -8.54M | -11.12M | -12.93M | -11.65M | -13.19M | -13.99M | -14.68M | -13.50M | -13.93M | -16.30M | -15.33M | -14.91M | -15.27M | -18.56M | -15.48M | -14.76M | -15.38M | -13.75M | -15.34M | -19.00M | |||||
| Non-operating items | |||||||||||||||||||||||||
| Non Operating Investment Income | -0.00M | -0.04M | -0.12M | -0.01M | 0.04M | 0.11M | |||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.02M | 0.14M | 0.13M | 0.14M | 0.22M | 0.52M | 0.83M | 1.17M | 0.86M | 0.75M | 0.80M | 0.83M | 0.55M | 0.42M | 0.44M | 0.32M | 0.42M | 1.86M | 1.36M | 1.08M | |||||
| Other Non Operating IncomeOther Non Op Inc. | -0.01M | -0.12M | -0.10M | -0.02M | 0.12M | 0.22M | 0.24M | 0.15M | 0.48M | 0.46M | 0.21M | 0.01M | 0.13M | 0.09M | 0.31M | 0.51M | 0.65M | ||||||||
| Net income details | |||||||||||||||||||||||||
| EBT | -8.53M | -10.97M | -12.79M | -11.50M | -12.97M | -13.47M | -13.85M | -12.34M | -13.07M | -15.55M | -14.52M | -14.09M | -14.73M | -18.14M | -15.05M | -14.43M | -14.96M | -11.89M | -13.97M | -17.92M | |||||
| Profit After TaxPAT | -8.54M | -10.83M | -12.90M | -11.53M | -12.84M | -13.15M | -13.60M | -12.19M | -12.60M | -15.08M | -14.31M | -14.08M | -14.60M | -18.05M | -15.05M | -14.43M | -14.96M | -11.58M | -13.46M | -17.44M | |||||
| Income from Continuing OperationsIncome (Continuing) | -8.53M | -10.97M | -12.79M | -11.50M | -12.97M | -13.47M | -13.85M | -12.34M | -13.07M | -15.55M | -14.52M | -14.09M | -14.73M | -18.14M | -15.05M | -14.43M | -14.96M | -11.89M | -13.97M | -17.92M | |||||
| Consolidated Net IncomeConsol Net Inc. | -8.53M | -10.97M | -12.79M | -11.50M | -12.97M | -13.47M | -13.85M | -12.34M | -13.07M | -15.55M | -14.52M | -14.09M | -14.73M | -18.14M | -15.05M | -14.43M | -14.96M | -11.89M | -13.97M | -17.92M | |||||
| Income towards Parent CompanyParent Net Inc | -8.53M | -10.97M | -12.79M | -11.50M | -12.97M | -13.47M | -13.85M | -12.34M | -13.07M | -15.55M | -14.52M | -14.09M | -14.73M | -18.14M | -15.05M | -14.43M | -14.96M | -11.89M | -13.97M | -17.92M | |||||
| Net Income towards Common StockholdersNet Income | -8.53M | -10.97M | -12.79M | -11.50M | -12.97M | -13.47M | -13.85M | -12.34M | -13.07M | -15.55M | -14.52M | -14.09M | -14.73M | -18.14M | -15.05M | -14.43M | -14.96M | -11.89M | -13.97M | -17.92M | |||||
| Additional items | |||||||||||||||||||||||||
| EPS (Basic) | -0.47 | -0.81 | -0.49 | -0.44 | -0.49 | -0.51 | -0.52 | -0.43 | -0.45 | -0.55 | -0.49 | -0.48 | -0.49 | -0.61 | -0.42 | -0.40 | -0.38 | -0.27 | -0.22 | -0.28 | |||||
| EPS (Diluted) | -0.47 | -0.81 | -0.49 | -0.44 | -0.49 | -0.51 | -0.52 | -0.43 | -0.45 | -0.55 | -0.49 | -0.48 | -0.49 | -0.61 | -0.42 | -0.40 | -0.38 | -0.27 | -0.22 | -0.28 | |||||
| Shares Outstanding | 18.29M | 13.61M | 26.36M | 26.39M | 26.39M | 26.39M | 26.44M | 28.65M | 29.27M | 28.42M | 29.37M | 29.65M | 29.84M | 29.98M | 35.53M | 35.99M | 39.67M | 44.01M | 64.66M | 64.70M | |||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 18.29M | 13.61M | 26.36M | 26.39M | 26.39M | 26.39M | 26.44M | 28.65M | 29.27M | 28.42M | 29.37M | 29.65M | 29.84M | 29.98M | 35.53M | 35.99M | 39.67M | 44.01M | 64.66M | 64.70M | |||||
| EBITDA | -8.54M | -11.12M | -12.93M | -11.65M | -13.19M | -13.99M | -14.68M | -13.50M | -13.93M | -16.30M | -15.33M | -14.91M | -15.27M | -18.56M | -15.48M | -14.76M | -15.38M | -13.75M | -15.34M | -19.00M |